$ACIC stock has now fallen 11% today, according to our price data from Polygon. There has been approximately $1,452,135 of trading volume.
Here is what we see in our data on $ACIC (you can track the company live on Quiver's $ACIC stock page):
$ACIC Insider Trading Activity
$ACIC insiders have traded $ACIC stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ACIC stock by insiders over the last 6 months:
- CHRISTOPHER GRIFFITH (Chief Operating Officer) sold 18,409 shares for an estimated $218,330
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ACIC Hedge Fund Activity
We have seen 68 institutional investors add shares of $ACIC stock to their portfolio, and 52 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BASTION ASSET MANAGEMENT INC. removed 373,073 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $4,249,301
- CITADEL ADVISORS LLC removed 251,984 shares (-68.7%) from their portfolio in Q3 2025, for an estimated $2,870,097
- PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. added 127,571 shares (+21.4%) to their portfolio in Q3 2025, for an estimated $1,453,033
- BRIDGEWAY CAPITAL MANAGEMENT, LLC added 110,179 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,254,938
- RENAISSANCE TECHNOLOGIES LLC added 93,700 shares (+35.9%) to their portfolio in Q3 2025, for an estimated $1,067,243
- KENNONDALE CAPITAL MANAGEMENT LLC added 85,456 shares (+inf%) to their portfolio in Q3 2025, for an estimated $973,343
- EMPOWERED FUNDS, LLC added 85,179 shares (+inf%) to their portfolio in Q3 2025, for an estimated $970,188
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
You can track data on $ACIC on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.